Heparin-coated circuits reduce the formation of TNFα during cardiopulmonary bypass

Acta Anaesthesiologica Scandinavica

Volumn 40, Issue 3, 1996, Pages 311-317

  Yamada, H ^a   Kudoh, I ^a   Hirose, Y ^a   Toyoshima, M ^a   Abe, H ^a   Kurahashi, K ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Cardiopulmonary bypass; Heparin coating; Inflammatory response; Interleukin 8; Neutrophil elastase; Tumor necrosis factor

Indexed keywords

HEPARIN; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; EXTRACORPOREAL CIRCULATION; HUMAN; INFLAMMATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0029986314     PISSN: 00015172     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-6576.1996.tb04438.x     Document Type: Article

References (29)

1. Kirklin JK, Westaby S, Blackstone EH, Kirklin JW, Chenoweth DE, Pacifico AD. Complement and the damaging effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg 1983: 86: 845-857.
2. Jansen NJG, van Oeveren W, Gu YJ, van Vliet MH, Eijsman L, Wildevuur CRH. Endotoxin release and tumor necrosis factor formation during cardiopulmonary bypass. Ann Thorac Surg 1992: 54: 744-748.
3. Baumann H, Gauldie J. The acute phase response. Immunol Today 1994: 15(2): 74-80.
4. Videm V, Svennevig JL, Fosse E, Semb G, Østerud A, Mollnes TE. Reduced complement activation with heparin-coated oxygenator and tubings in coronary bypass operations. J Thorac Cardiavasc Surg 1992: 103: 806-813.
5. Gu YJ, van Oeveren W, Akkerman C, Boonstra PW, Huyzen RJ, Wildevuur CRH. Heparin-coated circuits reduce the inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 1993: 55: 917-922.
6. Casey WF, Hauser GJ, Hannallah RS, Midgley FM, Khan WN. Circulating endotoxin and tumor necrosis factor during pediatric cardiac surgery. Crit Care Med 1992: 20: 1090-1096.
7. Ulich TR. Tumor necrosis factor. In: Kelley J, ed. Cytokines of the lung. New York: Dekker, 307-333. (Lenfant C, ed. Lung biology in health and disease; vol 61).
8. Ulich TR. Tumor necrosis factor. In: Kelley J, ed. Cytokines of the lung. New York: Dekker, 307-333. (Lenfant C, ed. Lung biology in health and disease; vol 61).
9. Chenoweth DE, Cooper SW, Hugli TE, Stewart RW, Blackstone EH, Kirklin JW. Complement activation during cardiopulmonary bypass. Evidence for generation of C3a and C5a anaphylatoxins. N Engl J Med 1981: 304: 497-503.
10. Kirklin JK, Chenoweth DE, Naftel DC, Blackstone EH, Kirklin JW. Effects of protamine administration after cardiopulmonary bypass on complement, blood elements, and the hemodynamic state. Ann Thorac Surg 1986: 41: 193-199.
11. Kazatchkine MD, Fearon DT, Silbert JE, Austin KF. Surface-associated heparin inhibits zymosan-induced activation of the human alternative complement pathway by augumenting the regulatory action of the control proteins on particle-bound C3b. J Exp Med 1979: 150: 1202-1215.
12. Kazatchkine MD, Fearon DT, Metcalfe DD, Rosenberg RD, Austen KF. Structural determination of the capacity of heparin to inhibit the formation of the human amplification C3 convertase. J Clin Invest 1981: 67: 223-228.
13. Frank MM, Fries LF. Complement. In: Paul WE ed. Fundamental Immunology. New York: Raven Press Ltd., 1989: 679-701.
14. Pekna M, Hagman L, Halden E, Nilsson UR, Nilsson B, Thelin S. Complement activation during cardiopulmonary bypass: Effects of immobilized heparin. Ann Thorac Surg 1994: 58: 421-424.
15. Mollnes TE, Viden V, Götze O, Harboe M, Oppermann M. Formation of C5a during cardiopulmonary bypass: Inhibition by precoating with heparin. Ann Thorac Surg 1991: 52: 92-97.
16. Tracey KJ, Cerami A. Tumor necrosis factor: An update review of its biology. Crit Care Med 1993: 21: S415-S422.
17. Schindler R, Gelfand JA, Dinarello CA. Recombinant C5a stimulates transcription rather than translation of interleukin-1(IL-1) and tumor necrosis factor: Translational signal provided by lipopolysaccharide or IL-1 itself. Blood 1990: 76(8): 1631-1638.
18. Cavaillon J-M, Fitting C, Haeffner-Cavaillon N. Recombinant C5a enhances interleukin1 and tumor necrosis factor release by lipopolysaccharide-stimulated monocytes and macrophages. Eur J Immunol 1990: 20: 253-257.
19. Strieter RM, Chensue SW, Basha MA, Standiford TJ, Lynch JP, Baggiolini M, Kunkel SL. Human alveolar macrophage gene expression of interleukin-8 by tumor necrosis factor-α, lipopolysaccharide, and interleukin-1β. Am J Respir Cell Mol Biol 1990: 2: 321-326.
20. Ulich TR, del Castillo J, Keys M, Granger GA, Ni R-X. Kinetics and mechanisms of recombinant human interleukin 1 and tumor necrosis factor-α-induced changes in circulating numbers of neutrophils and lymphocytes. J Immunol 1987: 139(10): 3406-3415.
21. Ulich TR, del Castillo J, Ni R-X, Bikhazi N, Calvin L. Mechanisms of tumor necrosis factor alpha-induced lymphopenia, neutropenia, and biphasic neutrophilia. J Leuk Biol 1989: 45: 155-167.
22. Wachtfogel YT, Kucich U, Greenplate J, et al. Human neutrophil degranuration during extracorporeal circulation. Blood 1987: 69(1): 324-330.
23. Riegel W, Spillner G, Schlosser V, Hörl WH. Plasma levels of main granulocyte components during cardiopulmonary bypass. J Thorac Cardiovasc Surg 1988: 95: 1014-1019.
24. Weller A, Isenmann S, Vestweber D. Cloning of the mouse endothelial selectins. J Biolog Chem 1992: 267(21): 15176-15183.
25. Thorp KM, Southern C, Bird IN, Matthews N. Tumor necrosis factor induction of ELAM-1 and ICAM-1 on human umbilical vein endothelial cells. Analysis of tumor necrosis factor - receptor interactions. Cytokine 1992: 4(4): 313-319.
26. Beutler B, Grau GE. Tumor necrosis factor in the pathogenesis of the infectious disease. Crit Care Med 1993: 21: S423-S435.
27. Redmond JM, Gillinov AM, Stuart RS, et al. Heparin-coated bypass circuits reduce pulmonary injury. Ann Thorac Surg 1993: 56: 474-479.
28. Jansen NJG, van Oeveren W, Broek Lvd, et al. Inhibition by dexamethasone of the reperfusion phenomena in cardiopulmonary bypass. J Cardiovasc Surg 1991: 102: 515-525.
29. Kawamura T, Inada K, Okada H, Okada K, Wakusawa R. Methylprednisolone inhibits increase of interleukin 8 and 6 during open heart surgery. Can J Anaesth 1995:42:399-403.